Literature DB >> 20333481

Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity.

Xinxin Yang1, Baohua Cheng.   

Abstract

Ketogenic diet (KD) is a high-fat, low-protein and low-carbohydrate diet. It is reported that KD can provide the neuroprotection for the neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease (PD) and amyotrophic lateral sclerosis. The main clinical symptom of PD is motor dysfunction derived from the loss of dopaminergic neurons in the substantia nigra (SN) and dopamine content in the striatum subsequently. It is well known that treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice produce motor dysfunction, biochemical, and neurochemical changes remarkably similar to idiopathic PD patients. In this study, we investigated the neuroprotective and anti-inflammatory effects of KD in MPTP-treated mice. The data showed that pretreatment with KD alleviated the motor dysfunction induced by MPTP. The decrease of Nissl-staining and tyrosine hydroxylase (TH)-positive neurons induced by MPTP was inhibited in the SN. The change of dopamine was very similar to dopaminergic neurons in the SN. KD inhibited the activation of microglia induced by MPTP in the SN. The levels of proinflammatory cytokines (interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha) in the SN were also decreased and induced by MPTP. So, we concluded that KD was neuroprotective and anti-inflammatory against MPTP-neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333481     DOI: 10.1007/s12031-010-9336-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.

Authors:  H Tanji; T Araki; H Nagasawa; Y Itoyama
Journal:  Brain Res       Date:  1999-04-10       Impact factor: 3.252

3.  PET study of 11C-acetoacetate kinetics in rat brain during dietary treatments affecting ketosis.

Authors:  M'hamed Bentourkia; Sébastien Tremblay; Fabien Pifferi; Jacques Rousseau; Roger Lecomte; Stephen Cunnane
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-27       Impact factor: 4.310

4.  D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.

Authors:  Kim Tieu; Celine Perier; Casper Caspersen; Peter Teismann; Du-Chu Wu; Shi-Du Yan; Ali Naini; Miquel Vila; Vernice Jackson-Lewis; Ravichandran Ramasamy; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats.

Authors:  Zhi-Gang Hu; Han-Dong Wang; Liang Qiao; Wei Yan; Qi-Fu Tan; Hong-Xia Yin
Journal:  Brain Inj       Date:  2009-05       Impact factor: 2.311

6.  Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.

Authors:  Hironori Yokoyama; Sho Takagi; Yu Watanabe; Hiroyuki Kato; Tsutomu Araki
Journal:  J Neural Transm (Vienna)       Date:  2008-01-31       Impact factor: 3.575

7.  Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition.

Authors:  L Massieu; M L Haces; T Montiel; K Hernández-Fonseca
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.

Authors:  C J Barnum; K L Eskow; K Dupre; P Blandino; T Deak; C Bishop
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

9.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

Review 10.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

View more
  47 in total

Review 1.  Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease.

Authors:  Rebecca C Schugar; Peter A Crawford
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

Review 2.  Purines and neuronal excitability: links to the ketogenic diet.

Authors:  S A Masino; M Kawamura; D N Ruskin; J D Geiger; D Boison
Journal:  Epilepsy Res       Date:  2011-08-30       Impact factor: 3.045

3.  A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.

Authors:  David N Ruskin; Jessica L Ross; Masahito Kawamura; Tiffany L Ruiz; Jonathan D Geiger; Susan A Masino
Journal:  Physiol Behav       Date:  2011-04-09

Review 4.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

5.  Ketogenic Diets for Adults With Highly Refractory Epilepsy.

Authors:  Tanya J W McDonald; Mackenzie C Cervenka
Journal:  Epilepsy Curr       Date:  2017 Nov-Dec       Impact factor: 7.500

6.  Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.

Authors:  Timothy A Simeone; Stephanie A Matthews; Kaeli K Samson; Kristina A Simeone
Journal:  Exp Neurol       Date:  2016-08-12       Impact factor: 5.330

7.  Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration.

Authors:  Mohammad Harun-Or-Rashid; Nate Pappenhagen; Peter G Palmer; Matthew A Smith; Victoria Gevorgyan; Gina N Wilson; Samuel D Crish; Denise M Inman
Journal:  J Neurosci       Date:  2018-05-14       Impact factor: 6.167

Review 8.  Ketone body metabolism and cardiovascular disease.

Authors:  David G Cotter; Rebecca C Schugar; Peter A Crawford
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-08       Impact factor: 4.733

9.  Clinical studies and anti-inflammatory mechanisms of treatments.

Authors:  Jacqueline A French; Matthias Koepp; Yvonne Naegelin; Federico Vigevano; Stéphane Auvin; Jong M Rho; Evan Rosenberg; Orrin Devinsky; Peder S Olofsson; Marc A Dichter
Journal:  Epilepsia       Date:  2017-07       Impact factor: 5.864

Review 10.  Neuroketotherapeutics: A modern review of a century-old therapy.

Authors:  Scott J Koppel; Russell H Swerdlow
Journal:  Neurochem Int       Date:  2017-06-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.